Health Care • Medical Specialities
$1.97 ▼ -0.07
(-3.43%)
MKT CAP: $5.7M • VOL: 15.3K
52W L $2 52W H $9
ACON // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $75.7K | $45.7K | $75.4K |
| YoY Revenue Growth % | +65.6% | -39.4% | — |
| Gross Profit | $6.8K | -$38.9K | — |
| Gross Margin % | 9.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$7.1M | -$5.5M | -$4.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$7.2M | -$7.0M | -$4.9M |
| EBITDA (Normalized) | -$7.0M | -$5.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$7.2M | -$5.3M | -$3.6M |
| Capital Expenditures (CapEx) | $21.5K | $5.1K | — |
| Free Cash Flow (FCF) | -$7.2M | -$5.3M | -$3.6M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $12.0M | $453.7K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $12.8M | $970.1K | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ACON.